Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues
医学
肝细胞癌
肝病学
酪氨酸激酶
癌症研究
内科学
蛋白酪氨酸激酶
酪氨酸激酶抑制剂
癌症
受体
作者
Shiye Yang,Huoqi Liang,Xing Li,Jiayi Qian,Zhibing Ming
出处
期刊:Hepatology International [Springer Science+Business Media] 日期:2024-02-08卷期号:18 (4): 1336-1337被引量:1